前列腺癌骨转移影像诊断方法研究进展

廖光星; 冷志欣; 肖国有; 廖光星; 冷志欣; 肖国有

doi:10.3760/cma.j.issn.1673-4114.2016.06.012

[1]

Gernone A, Bordonaro S, Tralongo P.Optimal sequence of bone target drugs in metastatic prostatic cancer[J].Expert Rev Anticancer Ther, 2015, 15(8):923-929. DOI:10.1586/14737140.2015.1054813.

[2]

Siegel R, Ma JM, Zou ZH, et al.Cancer statistics, 2014[J].CA Cancer J Clin, 2014, 64(1):9-29. DOI:10.3322/caac.21208.

[3]

Hu Y, Zhao Q, Rao J, et al.Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: a retrospective population-based cohort study, 2000-2009[J/OL].BMC Public Health, 2014, 14: 356[2016-04-28].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005468/. DOI: 10.1186/1471-2458-14-356.

[4]

Yasmin-Karim S, King MR, Messing EM, et al.E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis[J].Oncotarget, 2014, 5(23):12097-12110. DOI:10.18632/oncotarget.2503.

[5]

Choueiri MB, Tu SM, Yu-Lee LY, et al.The central role of osteoblasts in the metastasis of prostate cancer[J].Cancer Metastasis Rev, 2006, 25(4):601-609. DOI:10.1007/s10555-006-9034-y.

[6]

李建飞, 马梓友, 石贵宝, 等.前列腺癌骨转移的影像诊断分析[J].吉林医学, 2011, 32(29):6198-6199. DOI:10.3969/j.issn.1004-0412.2011.29.102.
Li JF, Ma ZY, Shi GB, et al.Imaging diagnostic analysis of prostate cancer bone metastases[J].Jilin Med J, 2011, 32(29):6198-6199. doi: 10.3969/j.issn.1004-0412.2011.29.102

[7]

齐红艳, 孙逊, 安锐.骨转移瘤影像学检查方法及相关进展[J].华中科技大学学报:医学版, 2015, 44(1):121-124. DOI:10.3870/j.issn.1672-0741.2015.01.025.
Qi HY, Sun X, An R.The examination method and related progress of bone metastases imaging[J].Acta Med Univ Sci Technol Huazhong, 2015, 44(1):121-124. doi: 10.3870/j.issn.1672-0741.2015.01.025

[8]

Buhmann Kirchhoff S, Becker C, Duerr HR, et al.Detection of osseous metastases of the spine:comparison of high resolution multi-detector-CT with MRI[J].Eur J Radiol, 2009, 69(3):567-573. DOI:10.1016/j.ejrad.2007.11.039.

[9]

李远章, 黄杰灵, 潘智越.螺旋CT在肿瘤骨转移诊断中的价值[J].中国医药指南, 2013, 11(21):481-482. DOI:10.3969/j.issn.1671-8194.2013.21.364.
Li YZ, Huang JL, Pan ZY.The value of spiral CT in tumor diagnosis of bone metastases[J].Guid Chin Med, 2013, 11(21):481-482. doi: 10.3969/j.issn.1671-8194.2013.21.364

[10]

Chagpar A, Babiera G, Aguirre J, et al.Variation in metastatic workup for patients with invasive breast cancer[J].Am J Surg, 2015, 210(6):1147-1154. DOI:10.1016/j.amjsurg.2015.06.032.

[11]

Cha MJ, Yoon YC.Clinical relevance of the apparent diffusion coefficient value of metastatic bone tumours on diffusion-weighted MRI images:differences according to the types of primary tumour, the affected bones, and clinical factors[J].ClinRadiol, 2015, 70(10):1116-1121. DOI:10.1016/j.crad.2015.05.015.

[12]

Rieden K.Conventional imaging and computerized tomography in diagnosis of skeletal metastases[J].Radiologe, 1995, 35(1):15-20.

[13]

Iagaru A, Young P, Mittra E, et al.Pilot prospective evaluation of ^99mTc-MDP scintigraphy, ¹⁸F NaF PET/CT, ¹⁸F FDG PET/CT and whole-body MRI for detection of skeletal metastases[J/OL].Clin Nucl Med, 2013, 38(7): e290-296[2016-04-28].http://www.ncbi.nlm.nih.gov/pubmed/23455520. DOI: 10.1097/RLU.0b013e3182815f64.

[14]

秦全波.前列腺癌脊椎骨转移CT、MRI检查的比较分析[J].中国实用医药, 2014, 9(25):100-101.
Qin QB.Comparative analysis of prostate cancer metastasis vertebrae in CT and MRI examination[J].China Prac Med, 2014, 9(25):100-101.

[15]

Bourillon C, Rahmouni A, Lin C, et al.Intravoxel incoherent motion diffusion-weighted imaging of multiple myeloma lesions:correlation with Whole-Body dynamic contrast agent-enhanced Mr imaging[J].Radiology, 2015, 277(3):773-783. DOI:10.1148/radiol.2015141728.

[16]

Giles SL, Desouza NM, Collins DJ, et al.Assessing myeloma bone disease with whole-body diffusion-weighted imaging:comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden[J].Clin Radiol, 2015, 70(6):614-621. DOI:10.1016/j.crad.2015.02.013.

[17]

Thoeny HC, De Keyzer F.Extracranial applications of diffusion-weighted magnetic resonance imaging[J].EurRadiol, 2007, 17(6):1385-1393.

[18]

Vilanova JC, Barceló J.Diffusion-weighted whole-body MR screening[J].Eur J Radiol, 2008, 67(3):440-447. DOI:10.1016/j.ejrad.2008.02.040.

[19]

张伟, 薛鹏, 尹所, 等.全身弥散加权成像诊断肿瘤骨转移的应用探讨[J].中国CT和MRI杂志, 2013, 11(2):91-93. DOI:10.3969/j.issn.1672-5131.2013.02.030.
Zhang W, Xue P, Yin S, et al.The clinical value of Whole-body diffusion weighted imaging on detection of bone metastasis[J].Chin J CT MRI, 2013, 11(2):91-93. doi: 10.3969/j.issn.1672-5131.2013.02.030

[20]

Garcia JR, Moreno C, Valls E, et al.Diagnostic performance of bone scintigraphy and ¹¹C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer[J].Rev Esp Med Nucl Imagen Mol, 2015, 34(3):155-161.

[21]

饶良俊, 王晓燕, 陈志丰, 等.对比分析^99mTc-MDP SPECT与¹⁸F-NaF PET/CT术前诊断肺癌骨转移的价值[J].中国医学影像技术, 2012, 28(12):2233-2238.
Rao LJ, Wang XY, Chen ZF, et al.Comparison of preoperative ^99mTc-MDP SPECT and ¹⁸F-NaF PET/CT in diagnosis of bone metastases in patients with lung cancer[J].Chin J Med Imaging Technol, 2012, 28(12):2233-2238.

[22]

王东, 孟宪平, 陈则君, 等.SPECT/CT融合图像与全身骨显像对骨转移瘤诊断的价值分析[J].中国CT和MRI杂志, 2016, 14(4):126-129. DOI:10.3969/j.issn.1672-5131.2016.04.038.
Wang D, Meng XP, Chen ZJ, et al.The diagnosis value analysis of SPECT/CT fusion images and whole body bone imaging for bone metastases[J].Chin J CT MRI, 2016, 14(4):126-129. doi: 10.3969/j.issn.1672-5131.2016.04.038

[23]

Haraldsen A, Bluhme H, Røhl L, et al.Single photon emission computed tomography(SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer[J].Clin Physiol Funct Imaging, 2016, 36(1):40-46. DOI:10.1111/cpf.12191.

[24]

张一秋, 石洪成, 顾宇参, 等.SPECT/CT骨显像对肺癌骨转移诊断的增益价值[J].中华核医学杂志, 2011, 31(4):219-222. DOI:10.3760/cma.j.issn.0253-9780.2011.04.002.
Zhang YQ, Shi HC, Gu YC, et al.The added diagnostic value of SPECT/CT imaging for bone metastases from lung cancer[J].Chin J Nucl Med, 2011, 31(4):219-222. doi: 10.3760/cma.j.issn.0253-9780.2011.04.002

[25]

Bailly M, Besse H, Kerdraon R, et al.¹⁸F-FDG PET/CT superscan in prostate cancer[J].Clin Nucl Med, 2014, 39(10):912-914. DOI:10.1097/RLU.0000000000000376.

[26]

Byun BH, Kong CB, Lim I, et al.Comparison of ¹⁸F-FDG PET/CT and ^99mTc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma[J].Skeletal Radiol, 2013, 42(12):1673-1681. DOI:10.1007/s00256-013-1714-4.

[27]

Beheshti M, Langsteger W, Fogelman I.Prostate cancer:role of SPECT and PET in imaging bone metastases[J].SeminNucl Med, 2009, 39(6):396-407. DOI:10.1053/j.semnuclmed.2009.05.003.

[28]

Rosen EL, Eubank WB, Mankoff DA.FDG PET, PET/CT, and breast cancer imaging[J].Radiographics, 2007, 27(Suppl 1):S215-229. DOI:10.1148/rg.27si075517.

[29]

Mojtahedi A, Solomon SB, Ulaner GA.Focused regional FDG PET/CT detects more osseous metastases than does whole-body PET/CT[J].Clin Nucl Med, 2013, 38(3):217-218. DOI:10.1097/RLU.0b013e31827a27ae.

[30]

彭婕, 董爱生, 左长京, 等.肺癌脊椎骨转移¹⁸F-FDG PET/CT与MRI的对比分析[J].医学影像学杂志, 2011, 21(10):1477-1480. DOI:10.3969/j.issn.1006-9011.2011.10.007.
Peng J, Dong AS, Zuo CJ, et al.Evaluation of ¹⁸F-FDG PET/CT and Mr imaging in the detection of spinal metastasis of lung cancer[J].J Med Imaging, 2011, 21(10):1477-1480. doi: 10.3969/j.issn.1006-9011.2011.10.007